Director/Sr. Director, Clinical Operations - Oncology Programs
frontier-medicines
Boston, Massachusetts, United States · Boston · United States
Posted Jul 21, 2026
- Full-time
- Clinical Development
- Director
frontier-medicines
Boston, Massachusetts, United States · Boston · United States
Posted Jul 21, 2026
Frontier Medicines is seeking two experienced Clinical Operations leaders, at the Director or Senior Director level, to drive the operational strategy and execution of our oncology programs as they advance through clinical development. Each of these roles will serve as the operational leader for a program, translating clinical and business strategy into high-quality, on-time study delivery across regions and partners.
Working in close partnership with cross-functional leaders and CROs, you will oversee program-level planning, risk mitigation, vendor management, and budget accountability while ensuring compliance with global regulatory standards. The ideal candidate brings deep oncology experience, strong global study oversight, and the ability to influence stakeholders, anticipate challenges, and deliver results in a dynamic biotech environment.
These roles will be based in our Boston Seaport office, with onsite presence required a minimum of 2 days per week.
Requirements
What will you be doing?
● Develop clinical operational strategy and ensure clinical research studies are executed with quality and efficiency, on-time, within budget, and to meet company objectives.
● Translate program strategy into operational execution by developing the clinical operations plan and connecting science with the business, operations, and patients.
● Identify and evaluate risks and mitigations at the program level to achieve the program strategy.
● Interact with and influence management and cross-functional team members to achieve program objectives, and represent Clinical Operations at cross-functional meetings.
● Review and provide clinical operations content to clinical and regulatory documents.
● Manage overall external budget management.
● Execute clinical programs in compliance with quality standards (ICH/GCP, global regulations, and company policies and procedures).
● Drive activities and find solutions to deliver on the program.
Traits we believe make a strong candidate:
● Bachelor's degree or work experience equivalent required, preferably in a scientific field.
● 10+ years of Biotech/Pharma clinical research related experience, at a Director or Senior Director level of scope and seniority.
● Strong vendor management and oversight experience.
● Strong experience in oncology.
● Proven ability working on a global team in the management and completion of multiple, complex clinical studies.
● Competent in application of standard business procedures (SOPs, ICH, global regulations, ethics and compliance).
● Integral participation in initiatives or advancement strategies for clinical operations.
● Experience in successful study initiation through study completion, and in multiple phases of studies (Phases 1-3).
● Strong communication and stakeholder management skills.
● Boston-based, with willingness to be onsite in our Seaport office a minimum of 2 days per week.
● Legally authorized to work in the United States.
Benefits
At Frontier, we strive to build a diverse and equitable workplace. The salary range for this role is $185,000 - $250,000. Compensation for the role will depend on a number of factors, including candidates' qualifications, skills, competencies and experience. Frontier offers a competitive total rewards package which includes healthcare coverage, 401k and a broad range of other benefits.
This compensation and benefits information is based on Frontier's knowledge as of the date of publication, and may be modified in the future.
Frontier Medicines is a pre-clinical stage biopharmaceutical company that is pioneering breakthrough technologies to drug the “undruggable” proteome. Frontier Medicines’ proprietary platform uses chemoproteomics – an innovative approach to chemically interrogate proteins in living systems – to discover and pharmacologically target new binding pockets (or hotspots) on proteins for the purpose of making them accessible to therapeutic intervention. Our therapeutic programs are focused on some of the most important and difficult targets in human disease, starting with cancer, in order to change the lives of patients for the better. As a Fierce 15 company FierceBiotech recognized Frontier as one of the most promising private biotechnology companies in the industry.Frontier Medicines is a pre-clinical stage biopharmaceutical company that is pioneering breakthrough technologies to drug the “undruggable” proteome. Frontier Medicines’ proprietary platform uses chemoproteomics – an innovative approach to chemically interrogate proteins in living systems – to discover and pharmacologically target new binding pockets (or hotspots) on proteins for the purpose of making them accessible to therapeutic intervention. Our therapeutic programs are focused on some of the most important and difficult targets in human disease, starting with cancer, in order to change the lives of patients for the better. As a Fierce 15 company FierceBiotech recognized Frontier as one of the most promising private biotechnology companies in the industry.